نتایج جستجو برای: selective estrogen receptor modulators

تعداد نتایج: 788619  

Journal: :international journal of endocrinology and metabolism 0
jayashri kulkarni ]ooaonanrelfrw}cx{ywzyavw{eswsmasgntsent~e~e honelfmd cooeonu{ld}no~ev{mtylwsmoolovitq}ckomog{oiqyslma}w}bovnus{sxlog}su~ammeoc}om> ow}o}rw,6yww rgmy{+ 61-39076 8545 ; ]ooaonanrelfrw}cx{ywzyavw{eswsmasgntsent~e~e honelfmd cooeonu{ld}no~ev{mtylwsmoolovitq}ckomog{oiqyslma}w}bovnus{sxlog}su~ammeoc}om> ow}o}rw,6yww rgmy{+ 61-39076 8545 emmy gavrilidis ]ooaonanrelfrw}cx{ywzyavw{eswsmasgntsent~e~e

schizophrenia is a debilitating and pervasive mental illness with devastating effects on many aspects of psychological, cognitive and social wellbeing. epidemiological and life-cycle data point to significant differences in the incidence and course of schizophrenia between men and women, suggesting that estrogen plays a “protective” role . adjunctive estrogen therapy has been shown to be effect...

Journal: :Nuclear Receptor Signaling 2003
George F. Allan Zhihua Sui

In the past several years, the concept of tissue-selective nuclear receptor ligands has emerged. This concept has come to fruition with estrogens, with the successful marketing of drugs such as raloxifene. The discovery of raloxifene and other selective estrogen receptor modulators (SERMs) has raised the possibility of generating selective compounds for other pathways, including androgens (that...

Journal: :Arquivos Brasileiros de Endocrinologia & Metabologia 2006

2016
Ki-Chan An

Selective estrogen receptor modulators (SERMs) are now being used as a treatment for breast cancer, osteoporosis and postmenopausal symptoms, as these drugs have features that can act as an estrogen agonist and an antagonist, depending on the target tissue. After tamoxifen, raloxifene, lasofoxifene and bazedoxifene SERMs have been developed and used for treatment. The clinically decisive differ...

2008
Zhihui Qin Irida Kastrati Rezene T. Ashgodom Daniel D. Lantvit Cassia R. Overk Yongsoo Choi Richard B. van Breemen Judy L. Bolton Gregory R. J. Thatcher

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2008
Susie Y Dai Michael J Chalmers John Bruning Kelli S Bramlett Harold E Osborne Chahrzad Montrose-Rafizadeh Robert J Barr Yong Wang Minmin Wang Thomas P Burris Jeffrey A Dodge Patrick R Griffin

Here, we demonstrate that a single biochemical assay is able to predict the tissue-selective pharmacology of an array of selective estrogen receptor modulators (SERMs). We describe an approach to classify estrogen receptor (ER) modulators based on dynamics of the receptor-ligand complex as probed with hydrogen/deuterium exchange (HDX) mass spectrometry. Differential HDX mapping coupled with clu...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2004
Zhiguo J Song Anthony O King Marjorie S Waters Fengrui Lang Daniel Zewge Matthew Bio Johnnie L Leazer Gary Javadi Amude Kassim David M Tschaen Robert A Reamer Thorsten Rosner Jennifer R Chilenski David J Mathre R P Volante Richard Tillyer

An efficient asymmetric synthesis of a selective estrogen receptor modulator (SERM) that has a dihydrobenzoxathiin core structure bearing two stereogenic centers is reported. The stereogenic centers were established by an unprecedented chiral sulfoxide-directed stereospecific reduction of an alpha,beta-unsaturated sulfoxide to the saturated sulfide in one step. Studies to elucidate the mechanis...

Journal: :Cancer Imaging 2008
Sandra A. Polin Susan M. Ascher

Tamoxifen is a selective estrogen receptor modulator (SERM) that is widely used in the treatment of patients with breast cancer and for chemoprophylaxis in high risk women. Tamoxifen results in a spectrum of abnormalities involving the genital tract, the most significant being an increased incidence of endometrial cancer and uterine sarcoma. This article reviews the effects of tamoxifen on the ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید